A systematic review and meta-analysis of published randomized controlled trials of combination of clopidogrel and aspirin in transient ischemic attack or minor stroke

Zhou,Xingjian; Tian,Jing; Zhu,Ming Zhen; He,Colin K.

doi:10.3892/etm.2017.4459

A systematic review and meta-analysis of published randomized controlled trials of combination of clopidogrel and aspirin in transient ischemic attack or minor stroke

Authors:
- Xingjian Zhou
- Jing Tian
- Ming Zhen Zhu
- Colin K. He
View Affiliations

Affiliations: Department of Endocrinology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China, Orient Health Care, StegoTech LLC, King of Prussia, PA 19406, USA
Published online on: May 17, 2017 https://doi.org/10.3892/etm.2017.4459
Pages: 324-332
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The use of antiplatelet agents in patients with ischemic stroke is recommended. In this study, we compared the efficacy and safety of the treatment of clopidogrel plus aspirin (ASA) and that of ASA alone in patients with mild stroke/transient ischemic attack (TIA). Randomized controlled trial (RCT) studies of Clop + ASA vs. ASA therapy in the patients with minor stroke/TIA were identified by electronic bibliographic searches. The primary result was recurrent stroke, while myocardial infarction (MI) as well as vascular mortalities were the secondary result, and major hemorrhagic events were the safety result. A comparative analysis of binary outcomes was performed on the treatment groups, with the employment of fixed effect models and the measurement of risk ratios (95% CI). Five RCT studies involving 9,527 patients were included. Compared with the group with ASA treatment, there was significant reduction in the incidence of recurrent stroke in the group with Clop + ASA (RR=0.76, 95% CI=0.67‑0.87, P<0.0001), and there was no significant increase in the incidence of vascular mortalities and MI (RR=1.08, 95% CI=0.83-1.41, P=0.56) and no significant change in major hemorrhagic events (RR=1.55, 95% CI=0.72‑3.36, P=0.26). Therefore, the treatment with Clop + ASA seems safe as well as effective for decreasing stroke recurrence. In addition, this is related to a statistically insignificant trend in increasing vascular mortalities, MI, and primary hemorrhagic events. These findings need to be confirmed in prospective studies.

View Figures

View References

1	Johnston SC, Fayad PB, Gorelick PB, Hanley DF, Shwayder P, van Husen D and and Weiskopf T: Prevalence and knowledge of transient ischemic attack among US adults. Neurology. 60:1429–1434. 2003. View Article : Google Scholar : PubMed/NCBI
2	Wang YL, Wu D, Liao X, Zhang W, Zhao X and Wang YJ: Burden of stroke in China. Int J Stroke. 2:211–213. 2007. View Article : Google Scholar : PubMed/NCBI
3	Zhao D, Liu J, Wang W, Zeng Z, Cheng J, Liu J, Sun J and Wu Z: Epidemiological transition of stroke in China: Twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke. 39:1668–1674. 2008. View Article : Google Scholar : PubMed/NCBI
4	Edlow JA, Kim S, Pelletier AJ and Camargo CA Jr.: National study on emergency department visits for transient ischemic attack, 1992–2001. Acad Emerg Med. 13:666–672. 2006. View Article : Google Scholar : PubMed/NCBI
5	Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, Lovelock CE, Binney LE, Bull LM, Cuthbertson FC, et al: Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): A prospective population-based sequential comparison. Lancet. 370:1432–1442. 2007. View Article : Google Scholar : PubMed/NCBI
6	Luengo-Fernandez R, Gray AM and Rothwell PM: Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): A prospective population-based sequential comparison. Lancet Neurol. 8:235–243. 2009. View Article : Google Scholar : PubMed/NCBI
7	Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, et al American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology, : Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 44:870–947. 2013. View Article : Google Scholar : PubMed/NCBI
8	Hankey GJ and Eikelboom JW: Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. Lancet Neurol. 9:273–284. 2010. View Article : Google Scholar : PubMed/NCBI
9	Moher D, Liberati A, Tetzlaff J and Altman DG; PRISMA Group, : Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 339:b25352009. View Article : Google Scholar : PubMed/NCBI
10	Higgins JPT and Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration; 2011
11	Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P and Schünemann HJ; GRADE Working Group, : GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 336:924–926. 2008. View Article : Google Scholar : PubMed/NCBI
12	Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002. View Article : Google Scholar : PubMed/NCBI
13	Egger M, Smith G Davey, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
14	Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, et al CHANCE investigators, : Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 369:11–19. 2013. View Article : Google Scholar : PubMed/NCBI
15	Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM and Buchan AM; FASTER Investigators, : Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial. Lancet Neurol. 6:961–969. 2007. View Article : Google Scholar : PubMed/NCBI
16	Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M and Ringelstein EB: Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 111:2233–2240. 2005. View Article : Google Scholar : PubMed/NCBI
17	Côté R, Zhang Y, Hart RG, McClure LA, Anderson DC, Talbert RL and Benavente OR: ASA failure: Does the combination ASA/clopidogrel confer better long-term vascular protection? Neurology. 82:382–389. 2014. View Article : Google Scholar : PubMed/NCBI
18	Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS and Pearce LA; SPS3 Investigators: Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 367:817–825. 2012. View Article : Google Scholar : PubMed/NCBI
19	Geeganage CM, Diener HC, Algra A, Chen C, Topol EJ, Dengler R, Markus HS, Bath MW and Bath PM; Acute Antiplatelet Stroke Trialists Collaboration, : Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: Systematic review and meta-analysis of randomized controlled trials. Stroke. 43:1058–1066. 2012. View Article : Google Scholar : PubMed/NCBI
20	Palacio S, Hart RG, Pearce LA and Benavente OR: Effect of addition of clopidogrel to aspirin on mortality: Systematic review of randomized trials. Stroke. 43:2157–2162. 2012. View Article : Google Scholar : PubMed/NCBI
21	Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, Han Z, Tan KS, Ratanakorn D, Chollate P, et al CLAIR study investigators, : Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial. Lancet Neurol. 9:489–497. 2010. View Article : Google Scholar : PubMed/NCBI
22	Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, Dillon C, Elm J, Lindblad A, Morgenstern L, et al: Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: Rationale and design. Int J Stroke. 8:479–483. 2013. View Article : Google Scholar : PubMed/NCBI